பொதுவானது ஸ்டாக் கொள்முதல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பொதுவானது ஸ்டாக் கொள்முதல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பொதுவானது ஸ்டாக் கொள்முதல் Today - Breaking & Trending Today

Paleo Resources Announces Transaction With Field Genie, Inc.


Paleo Resources Announces Transaction With Field Genie, Inc.
CALGARY, Alberta, April 01, 2021 (GLOBE NEWSWIRE) Paleo Resources, Inc. (“Paleo” or the “Corporation”) (TSX-V: PRE, OTCQB: PRIEF) announces that it has entered into a Common Stock Purchase and License Agreement with Field Genie, Inc. Field Genie, Inc. is a technology service provider that uses advanced artificial intelligence techniques to deliver solutions using spatial/geo intelligence and computer vision, including real-time detection and recognition of objects and patterns.
Material terms of the agreement are as follows:
(a)
  
Field Genie, Inc. to provide Paleo (and its subsidiaries as directed by Paleo) technology development services during the 12 month term of the Agreement, with a focus on further development and build out of the digital investment platform of Energy Funders Resources, Paleo’s indirect wholly owned subsidiary. ....

United States , San Antonio , Rogers Braugh Jr , Piyush Prakash , Energy Funders Resources , Founder Of Field Genie Inc , Paleo Resources Inc , Field Genie Inc , Venture Exchange , Paleo Resources , Common Stock Purchase , License Agreement , Field Genie , Chief Executive Officer , Debt Settlement , ஒன்றுபட்டது மாநிலங்களில் , சான் அன்டோனியோ , பியூஷ பிரகாஷ் , ஆற்றல் நிதி வழங்குநர்கள் வளங்கள் , நிறுவனர் ஆஃப் புலம் ஜீநீ இன்க் , பேலியோ வளங்கள் இன்க் , புலம் ஜீநீ இன்க் , துணிகர பரிமாற்றம் , பேலியோ வளங்கள் , பொதுவானது ஸ்டாக் கொள்முதல் , புலம் ஜீநீ ,

Oncolytics Biotech® Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights


Oncolytics Biotech® Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
News provided by
Share this article
- Clinical demonstration of pelareorep reversing immunosuppressive tumor microenvironments
- On track to report clinical biomarker and safety data in breast cancer in 2021
- Strong financial foundation with approximately $50 million in cash on hand and cash runway to H2 2022
- Management hosting conference call and webcast today at 8:30 am ET
SAN DIEGO and CALGARY, AB, March 5, 2021 /PRNewswire/ Oncolytics Biotech
® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced its financial results and operational highlights for the quarter and year ended December 31, 2020. All dollar amounts are expressed in Canadian currency unless otherwise noted. ....

United States , United Kingdom , Matt Coffey , Oncolytic Reovirus Pelareorep , Timothy Mccarthy , Merck Kgaa Darmstadt , Oncolytics Biotech Inc , American Society Of Clinical Oncology , Company Contact , Ohio State University Comprehensive Cancer Center , Rutgers Cancer Institute Of New Jersey , Brain Tumor Charity , Society Of Neuro , Merck Kga , Breast Cancer Program , American Cancer Society , Hematologic Malignancies Program , American Cancer Society Inc , Cancer Research United Kingdom , Gastrointestinal Cancer Program , Oncolytics Biotech , Merck Kgaa , Securities Exchange , University Of Leeds , Chief Executive Officer , Demonstrating Pelareorep ,